CDSCO Notification 2026: SUGAM Portal Application Rejection Rules & Long Pending Applications

CDSCO Notification 2026: SUGAM Portal Application Rejection Rules & Long Pending Applications

What is the CDSCO new rule for long pending applications in 2026?

 The Central Drugs Standard Control Organization (CDSCO) has announced that long-pending applications on the SUGAM Portal will be rejected if applicants fail to respond to queries within the given timeline.

This CDSCO notification 2026 in India aims to reduce the growing backlog of drug approval applications in India, especially for pharmaceutical companies, importers, and regulatory professionals operating across Indian states.

What happens if you don’t respond to CDSCO queries?

 Your application will be permanently rejected, and the application fee will be forfeited.

What is the CDSCO Notice About?

The latest CDSCO public notice (May 2026) highlights that many applications are delayed because applicants have not responded to queries raised during evaluation.

To fix this issue, CDSCO has introduced a structured reminder system for all pending applications on the SUGAM online portal.

CDSCO Reminder System for Pending Applications on SUGAM Portal

To ensure timely action, CDSCO will follow a 4-step reminder process:

● 1st Reminder → Sent to applicant

● 2nd Reminder →  30 days

● 3rd Reminder → After another 30 days

● Final Disposal Notice → After another 30 days

This system applies to applications across divisions including:

●   GCT

●   BA/BE

●   Ethics Committee

●   Veterinary

CDSCO Application Rejection Rules 2026 (Must Know for SUGAM Portal Users)

If applicants fail to respond even after multiple reminders:

● The application will be rejected permanently

● The application fee will be forfeited

●   No further processing will be allowed

This is one of the most important CDSCO application rejection rules in 2026

Special Update for Old Applications

Applications that have been:

●   Pending for more than 2 years

These will now be:

● Rejected within 30 days from the notice date

This is part of CDSCO’s effort to clear long-standing application backlog.

Why This Update Matters for Pharma Companies

This CDSCO update directly impacts pharmaceutical companies and regulatory professionals in India, including:

●   Pharma manufacturers

●   Importers

●   Clinical trial applicants

●   Regulatory professionals

Key Risks:

●   Loss of application fees

●   Delay in drug approval India

●   Compliance issues

Benefits:

●   Faster processing of active applications

●   Improved transparency in CDSCO application process

How to Avoid CDSCO Application Rejection

To stay compliant with CDSCO guidelines, follow these steps:

● Regularly check your SUGAM portal application status

●   Respond to all queries within the deadline

●   Maintain proper documentation

●   Track regulatory submission timelines

●   Assign a compliance team for monitoring

This update is part of the evolving CDSCO guidelines for drug approval and regulatory compliance in India.

Conclusion

The Central Drugs Standard Control Organization (CDSCO) has introduced strict rules to clear long-pending applications on the SUGAM Portal. Under the CDSCO notification 2026, failure to respond to queries can lead to application rejection and fee forfeiture in India.

FAQs

1. What is the new CDSCO rule for long-pending applications in 2026?

The Central Drugs Standard Control Organization (CDSCO) has announced that applications pending on the SUGAM Portal will be rejected if applicants fail to respond to queries within the given timeline after multiple reminders.

2. How many reminders does CDSCO send before rejecting an application?

CDSCO sends three reminders at 30-day intervals, followed by a final disposal notice. If there is still no response, the application is rejected.

3. What happens if you don’t respond to CDSCO queries?

If you fail to respond, your application will be permanently rejected, and the application fee will be forfeited with no further processing.

4. Which applications are most affected by this CDSCO update?

This rule mainly affects pharma companies, importers, clinical trial applicants, and regulatory professionals in India who have pending applications on the SUGAM portal.

5. How can you avoid CDSCO application rejection?

To avoid rejection, regularly check your SUGAM portal status, respond to all queries on time, maintain proper documentation, and follow CDSCO guidelines carefully.

Access the official document for CDSCO Disposal of Long Pending Applications 2026: SUGAM Portal Rejection Rules in India

Note:
Cases related to Pharmaceuticals are highly technical and knowledge-driven. If you're searching for a drugs and cosmetics lawyer in India, a pharmaceutical lawyer, Mace Corporate Associates is the perfect place. If you are searching for a DPCO Lawyer for overcharging cases or DPCO Compliance, Mace can assist you well. May it be a clinical trial Lawyer or a Medical device lawyer, Mace can be of great and perfect match for Pharmaceutical litigation. Mace has an accomplished track record for Not of Standard Quality Cases, Licensing Cases etc.